Company Profile for Masimo

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve patient outcomes and reduce the cost of care. Masimo SET Measure-through Motion and Low Perfusion„¢ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.1 Masimo SET has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,2 improve CCHD screening in newborns,3 and, when used for continuous monitoring with Masimo Patient SafetyNet„¢ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.4-6 Masimo SET is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world,7 and is the primary pulse oximetry at 9 of the top 10 hospitals listed in the 2018-19 U.S. News and World Report Best Hospitals Honor Roll.8 Masimo continues to refine SET and in 2018, announced that SpO2 accuracy on RD SET„¢ sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patients physiological status. In 2005, Masimo introduced rainbow Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb), oxygen content (SpOC„¢), carboxyhemoglobin (SpCO), methemoglobin (SpMet), Pleth Variability Index (PVi), RPVi„¢ (rainbow PVi), and Oxygen Reserve Index (ORi„¢). In 2013, Masimo introduced the Root Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine Brain Function Monitoring, O3 Regional Oximetry, and ISA„¢ Capnography with NomoLine sampling lines. Masimos family of continuous and spot-check monitoring Pulse CO-Oximeters includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7 and Radius„¢ PPG, portable devices like Rad-67„¢, fingertip pulse oximeters like MightySat Rx, and devices available for use both in the hospital and at home, such as Rad-97„¢. Masimo hospital automation and connectivity solutions are centered around the Iris platform, and include Iris Gateway„¢, Patient SafetyNet, Replica„¢, Halo ION„¢, UniView„¢, and Doctella„¢. Additional information about Masimo and its products may be found at Published clinical studies on Masimo products can be found at

ORi and RPVi have not received FDA 510(k) clearance and are not available for sale in the United States. The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.


Global Banking & Finance Jobs
Search Jobs or Projects Worldwide
  1. Published clinical studies on pulse oximetry and the benefits of Masimo SET can be found on our website at Comparative studies include independent and objective studies which are comprised of abstracts presented at scientific meetings and peer-reviewed journal articles.
  2. Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants through Changes in Clinical Practice and SpO2 Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
  3. de-Wahl Granelli A et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338.
  4. Taenzer AH et al. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010:112(2):282-287.
  5. Taenzer A et al. Postoperative Monitoring “ The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter. Spring-Summer 2012.
  6. McGrath SP et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.
  7. Estimate: Masimo data on file.
Company: Masimo
Headquarters Address: 52 Discovery
Irvine, CA 92618
Main Telephone: 949-297-7000

Ticker/ISIN: MASI(NASDAQ)/US5747951003
Type of Organization: Public
Industry: Medical Devices
Key Executives: CEO: Joe Kiani
Public Relations
Contact: Evan Lamb
Phone: 949-396-3376

[email protected]

Investor Relations
Contact: Eli Kammerman
Phone: 949-297-7077

[email protected]